These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 2170734)

  • 1. Vitamin D and bone.
    Stern PH
    Kidney Int Suppl; 1990 Sep; 29():S17-21. PubMed ID: 2170734
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective biological response by target organs (intestine, kidney, and bone) to 1,25-dihydroxyvitamin D3 and two analogues.
    Norman AW; Sergeev IN; Bishop JE; Okamura WH
    Cancer Res; 1993 Sep; 53(17):3935-42. PubMed ID: 8395333
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The vitamin D hormone and its nuclear receptor: molecular actions and disease states.
    Haussler MR; Haussler CA; Jurutka PW; Thompson PD; Hsieh JC; Remus LS; Selznick SH; Whitfield GK
    J Endocrinol; 1997 Sep; 154 Suppl():S57-73. PubMed ID: 9379138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Physiological importance of vitamin D metabolism.
    Haussler MR; Chandler JS; Pike JW; Brumbaugh PF; Speer DP; Pitt MJ
    Prog Biochem Pharmacol; 1980; 17():134-42. PubMed ID: 6259650
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fluoride substitution of vitamin D analogs at C-26 and C-27: enhancement of activity of 25-hydroxyvitamin D but not of 1,25-dihydroxyvitamin D on bone and intestine in vitro.
    Stern PH; Mavreas T; Tanaka Y; DeLuca HF; Ikekawa N; Kobayashi Y
    J Pharmacol Exp Ther; 1984 Apr; 229(1):9-13. PubMed ID: 6323693
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A-ring analogues of 1, 25-(OH)2D3 with low affinity for the vitamin D receptor modulate chondrocytes via membrane effects that are dependent on cell maturation.
    Greising DM; Schwartz Z; Posner GH; Sylvia VL; Dean DD; Boyan BD
    J Cell Physiol; 1997 Jun; 171(3):357-67. PubMed ID: 9180905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vitamin D and the hematolymphopoietic tissue: a 1994 update.
    Manolagas SC; Yu XP; Girasole G; Bellido T
    Semin Nephrol; 1994 Mar; 14(2):129-43. PubMed ID: 8177980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of epidermal growth factor receptor levels by 1,25-dihydroxyvitamin D3 in human breast cancer cells.
    Koga M; Eisman JA; Sutherland RL
    Cancer Res; 1988 May; 48(10):2734-9. PubMed ID: 2834048
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of mycotoxins aflatoxin B1 and T-2 toxin on the vitamin D3 metabolism and binding of its hormonal form 1,25-dihydroxyvitamin D3 in rats].
    Sergeev IN; Arkhapchev IuP; Kravchenko LV; Kodentsova VM; Piliia NM
    Vopr Med Khim; 1988; 34(4):51-7. PubMed ID: 2848363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Maturation-dependent regulation of protein kinase C activity by vitamin D3 metabolites in chondrocyte cultures.
    Sylvia VL; Schwartz Z; Schuman L; Morgan RT; Mackey S; Gomez R; Boyan BD
    J Cell Physiol; 1993 Nov; 157(2):271-8. PubMed ID: 8227160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Immune modulation by vitamin D analogs in the prevention of autoimmune diseases].
    Bouillon R; Verstuyf A; Branisteanu D; Waer M; Mathieu C
    Verh K Acad Geneeskd Belg; 1995; 57(5):371-85; discussion 385-7. PubMed ID: 8571669
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Morphology and biochemistry of bone remodeling: possible control by vitamin D, parathyroid hormone, and other substances.
    Huffer WE
    Lab Invest; 1988 Oct; 59(4):418-42. PubMed ID: 3050272
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alterations in serum and urine parameters reflecting bone turnover in uremic patients during treatment with 1,25-dihydroxyvitamin D3 and 24,25-dihydroxyvitamin D3.
    Mortensen BM; Gordeladze JO; Lyngdal PT; Aarseth HP; Gautvik KM
    Miner Electrolyte Metab; 1993; 19(2):78-85. PubMed ID: 8377728
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vitamin D: recent advances.
    DeLuca HF; Schnoes HK
    Annu Rev Biochem; 1983; 52():411-39. PubMed ID: 6311080
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence for the functional involvement of protein kinase C in the action of 1,25-dihydroxyvitamin D3 in bone.
    van Leeuwen JP; Birkenhäger JC; van den Bemd GJ; Buurman CJ; Staal A; Bos MP; Pols HA
    J Biol Chem; 1992 Jun; 267(18):12562-9. PubMed ID: 1320001
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of vitamin D in bone resorption.
    Suda T; Takahashi N; Abe E
    J Cell Biochem; 1992 May; 49(1):53-8. PubMed ID: 1644855
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Vitamin D Receptor in Osteoblast-Lineage Cells Is Essential for the Proresorptive Activity of 1α,25(OH)2D3 In Vivo.
    Mori T; Horibe K; Koide M; Uehara S; Yamamoto Y; Kato S; Yasuda H; Takahashi N; Udagawa N; Nakamichi Y
    Endocrinology; 2020 Nov; 161(11):. PubMed ID: 32987399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of 1,25-dihydroxyvitamin D3 on osteoblastic MC3T3-E1 cells.
    Kurihara N; Ishizuka S; Kiyoki M; Haketa Y; Ikeda K; Kumegawa M
    Endocrinology; 1986 Mar; 118(3):940-7. PubMed ID: 3004901
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Osteoblast differentiation and control by vitamin D and vitamin D metabolites.
    van Driel M; Pols HA; van Leeuwen JP
    Curr Pharm Des; 2004; 10(21):2535-55. PubMed ID: 15320744
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.